FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Stakeholders Look to Improve Patient Engagement

[ Price : $8.95]

A stakeholder dialog sponsored by the National Health Council and Genetic Alliance identifies barriers to improving patient engage...

Mobile App Maker Agrees to Stop Deceptive Claims

[ Price : $8.95]

Carrot Neurotechnology and its owners have agreed to stop making deceptive claims that their Ultimeyes app can improve users visio...

Consultants Estimates on Biosimilar Work Load and Costs

[ Price : $8.95]

Eastern Research Group publishes its interim estimates of FDA workload and costs in processing biosimilars during the first 30 mon...

Amgen Sues Hospira Over Epogen Biosimilar Submission

[ Price : $8.95]

Amgen files suit against Hospira over its alleged failure to disclose to Amgen its manufacturing information under the Biologics P...

Judge Dismisses Treanda Failure-to-Warn Case

[ Price : $8.95]

A New York federal judge says labeling for Cephalons Treanda adequately warned of potential adverse effects cited in a failure-to-...

FDA Clears Advanced Catheter Therapies Delivery Catheter

[ Price : $8.95]

FDA clears an Advanced Catheter Therapies (ACT) 510(k) for the Occlusion Perfusion Catheter that allows additional sizes for the u...

Science Board Group Sees FDA Science Progress

[ Price : $8.95]

A Science Board subcommittee acknowledges FDA science improvements since a critical 2007 report and urges additional steps in the ...

FDA Warning on Dosing Errors with Avycaz

[ Price : $8.95]

FDA issues a warning on the risk for dosing errors with Forest Pharmaceuticals intravenous antibacterial drug Avycaz (ceftazidime ...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Chaotic Labz, CMP Industries, NSC Pearson, and Sironis.

Info on Samples and Protocols Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on request for samples and protocols to the Office of Ma...